Search

Search Constraints

You searched for: Author/Creator Cressey, Tim R.

Search Results

1. A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines. Issue 2 (February 2018)

2. A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz‐Based Regimens. (24th February 2016)

3. Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates. (15th August 2017)

4. Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals. (1st January 2018)

5. Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings. (1st February 2020)

6. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Issue 9 (September 2022)

7. Efavirenz Concentrations and Probability of HIV Replication in Children. Issue 11 (November 2015)

9. Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult Formulations. Issue 12 (27th July 2021)

10. Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult Formulations. Issue 12 (December 2021)